Human α-defensin as a biosensor of interstitial lung diseases. An ex-vivo study

G. Paone, F. Carbone, G. Lucantoni, G. Galluccio, E. Li Bianchi, P. Di Giacomo, P. Regimenti, A. Perrone, G. Munafo‘, G. Schmid (Rome, Italy)

Source: Annual Congress 2006 - Airway biology and pathology
Session: Airway biology and pathology
Session type: Electronic Poster Discussion
Number: 2018
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Paone, F. Carbone, G. Lucantoni, G. Galluccio, E. Li Bianchi, P. Di Giacomo, P. Regimenti, A. Perrone, G. Munafo‘, G. Schmid (Rome, Italy). Human α-defensin as a biosensor of interstitial lung diseases. An ex-vivo study. Eur Respir J 2006; 28: Suppl. 50, 2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

Epidemiology of interstitial lung diseases. The RENIA study
Source: Eur Respir J 2001; 18: Suppl. 33, 440s
Year: 2001

Human lung scaffolds to model lung disease and tissue regeneration
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


B-cell infiltration varies among patients with interstitial lung diseases
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Volumetric texture analysis in the characterisation of interstitial lung diseases in lung transplant patients.
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017

Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Effect of pirfenidone (PFD) on cytokine/chemokine release from alveolar macrophages (AMs) in interstitial lung diseases (ILD): Preliminary results
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018

Bacterial culture results in patients with interstitial lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003

Role of imaging in progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018
Year: 2018



B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017


Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Interstitial lung diseases associated with lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Efficacy of functionalized-imatinib loaded gold nanoparticles on lung fibroblastoid cells from systemic sclerosis patients
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020